166 related articles for article (PubMed ID: 2212009)
1. Polyclonal B cell activation in lupus-prone mice precedes and predicts the development of autoimmune disease.
Klinman DM
J Clin Invest; 1990 Oct; 86(4):1249-54. PubMed ID: 2212009
[TBL] [Abstract][Full Text] [Related]
2. Development of the autoimmune B cell repertoire in MRL-lpr/lpr mice.
Klinman DM; Eisenberg RA; Steinberg AD
J Immunol; 1990 Jan; 144(2):506-11. PubMed ID: 2295800
[TBL] [Abstract][Full Text] [Related]
3. Autoantibody production is associated with polyclonal B cell activation in autoimmune mice which express the lpr or gld genes.
Ishigatsubo Y; Steinberg AD; Klinman DM
Eur J Immunol; 1988 Jul; 18(7):1089-93. PubMed ID: 3261246
[TBL] [Abstract][Full Text] [Related]
4. Polyclonal B cell activation arises from different mechanisms in lupus-prone (NZB x NZW)F1 and MRL/MpJ-lpr/lpr mice.
Merino R; Iwamoto M; Fossati L; Izui S
J Immunol; 1993 Dec; 151(11):6509-16. PubMed ID: 7902378
[TBL] [Abstract][Full Text] [Related]
5. Comparison of in vitro and in vivo mitogenic and polyclonal antibody and autoantibody responses to peptidoglycan, LPS, protein A, PWM, PHA and Con A in normal and autoimmune mice.
Dziarski R
J Clin Lab Immunol; 1985 Feb; 16(2):93-109. PubMed ID: 3886911
[TBL] [Abstract][Full Text] [Related]
6. Immunologic abnormality in NZB/NZW F1 mice. Thymus-independent occurrence of B cell abnormality and requirement for T cells in the development of autoimmune disease, as evidenced by an analysis of the athymic nude individuals.
Mihara M; Ohsugi Y; Saito K; Miyai T; Togashi M; Ono S; Murakami S; Dobashi K; Hirayama F; Hamaoka T
J Immunol; 1988 Jul; 141(1):85-90. PubMed ID: 3259971
[TBL] [Abstract][Full Text] [Related]
7. Responses of B cells from autoimmune mice to IL-5.
Umland SP; Go NF; Cupp JE; Howard M
J Immunol; 1989 Mar; 142(5):1528-35. PubMed ID: 2783944
[TBL] [Abstract][Full Text] [Related]
8. Transgene-mediated hyper-expression of IL-5 inhibits autoimmune disease but increases the risk of B cell chronic lymphocytic leukemia in a model of murine lupus.
Wen X; Zhang D; Kikuchi Y; Jiang Y; Nakamura K; Xiu Y; Tsurui H; Takahashi K; Abe M; Ohtsuji M; Nishimura H; Takatsu K; Shirai T; Hirose S
Eur J Immunol; 2004 Oct; 34(10):2740-9. PubMed ID: 15368290
[TBL] [Abstract][Full Text] [Related]
9. Acquisition and maturation of expressed B cell repertoires in normal and autoimmune mice.
Klinman DM; Ishigatsubo Y; Steinberg AD
J Immunol; 1988 Aug; 141(3):801-6. PubMed ID: 3260912
[TBL] [Abstract][Full Text] [Related]
10. Treatment with high doses of anti-IgM prevents, but with lower doses accelerates autoimmune disease in (NZW x BXSB)F1 hybrid mice.
Cerny A; Starobinski M; Hügin AW; Sutter S; Zinkernagel RM; Izui S
J Immunol; 1987 Jun; 138(12):4222-8. PubMed ID: 3495583
[TBL] [Abstract][Full Text] [Related]
11. CD4+ T cell lines with selective patterns of autoreactivity as well as CD4- CD8- T helper cell lines augment the production of idiotypes shared by pathogenic anti-DNA autoantibodies in the NZB x SWR model of lupus nephritis.
Sainis K; Datta SK
J Immunol; 1988 Apr; 140(7):2215-24. PubMed ID: 2965184
[TBL] [Abstract][Full Text] [Related]
12. Similarities in B cell repertoire development between autoimmune and aging normal mice.
Klinman DM
J Immunol; 1992 Mar; 148(5):1353-8. PubMed ID: 1538120
[TBL] [Abstract][Full Text] [Related]
13. Anti-immunoglobulin autoantibodies are not preferentially induced in polyclonal activation of human and mouse lymphocytes, and more anti-DNA and anti-erythrocyte autoantibodies are induced in polyclonal activation of mouse than human lymphocytes.
Dziarski R
J Immunol; 1984 Nov; 133(5):2537-44. PubMed ID: 6207235
[TBL] [Abstract][Full Text] [Related]
14. Polyclonal B cell activation by a B cell differentiation factor, B151-TRF2. III. B151-TRF2 as a B cell differentiation factor closely associated with autoimmune disease.
Dobashi K; Ono S; Murakami S; Takahama Y; Katoh Y; Hamaoka T
J Immunol; 1987 Feb; 138(3):780-7. PubMed ID: 3543118
[TBL] [Abstract][Full Text] [Related]
15. Terminal deoxynucleotidyl transferase deficiency reduces the incidence of autoimmune nephritis in (New Zealand Black x New Zealand White)F1 mice.
Conde C; Weller S; Gilfillan S; Marcellin L; Martin T; Pasquali JL
J Immunol; 1998 Dec; 161(12):7023-30. PubMed ID: 9862739
[TBL] [Abstract][Full Text] [Related]
16. Protection against renal disease in (NZB x NZW)F(1) lupus-prone mice after somatic B cell gene vaccination with anti-DNA immunoglobulin consensus peptide.
Ferrera F; Hahn BH; Rizzi M; Anderson M; Fitzgerald J; Millo E; Indiveri F; Shi FD; Filaci G; La Cava A
Arthritis Rheum; 2007 Jun; 56(6):1945-53. PubMed ID: 17530718
[TBL] [Abstract][Full Text] [Related]
17. Cross-reactivity of IgG and IgM secreting B cells in normal and autoimmune mice.
Klinman DM
J Autoimmun; 1994 Feb; 7(1):1-11. PubMed ID: 8198696
[TBL] [Abstract][Full Text] [Related]
18. Autoimmune syndrome after induction of neonatal tolerance to alloantigens. CD4+ T cells from the tolerant host activate autoreactive F1 B cells.
Merino J; Schurmans S; Duchosal MA; Izui S; Lambert PH
J Immunol; 1989 Oct; 143(7):2202-8. PubMed ID: 2570803
[TBL] [Abstract][Full Text] [Related]
19. Increased spontaneous polyclonal activation of B lymphocytes in mice with spontaneous autoimmune disease.
Izui S; McConahey PJ; Dixon FJ
J Immunol; 1978 Dec; 121(6):2213-9. PubMed ID: 363941
[TBL] [Abstract][Full Text] [Related]
20. B cell apoptosis accelerates the onset of murine lupus.
Trébéden-Nègre H; Weill B; Fournier C; Batteux F
Eur J Immunol; 2003 Jun; 33(6):1603-12. PubMed ID: 12778478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
